Bluebird

FDA Approves Bluebird Bio’s Gene Therapy for a Rare Neurological Disorder

1517d BY Reuters
Bluebird’s $2.8 Million Gene Therapy Becomes Most Expensive Drug After US Approval

1547d BY Reuters
Beautiful Mountain Bluebirds Are the BLUEST of All Bluebirds–and They’re on the Rise

2242d BY Epoch Inspired Staff
American Express and Wal-Mart’s Bluebird Venture

5125d BY Heide B. Malhotra